Investment Committee Summary
| Rating | HOLD |
| Internal 5-tier | HOLD |
| Classification · conviction | high-risk optionality · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $799 (-23% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $1,005 (-3% vs spot · 12m PWEV) |
| Next catalyst | 2026-09-01 — Ex-dividend $5.00/sh |
| Primary thesis-break | Net interest margin < mid-cycle assumption by 20bps or more (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: HOLD
Internal 5-tier: HOLD · high-risk optionality · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $1,036 |
| Triangulated Fair Value | $799 (-23% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $1,005 (-3% vs spot · 12m PWEV) |
| Forward P/E | 18.4x |
| Market Cap | $307B |
| 52-Week Range | $678–$1,152 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — an intrinsic DCF, a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 54.4/100 (35th pct) | -3% 1yr expected | Hold | Long Stock | 7d — Ex-dividend $5.00/sh |
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: HOLD
Balanced: triangulated fair value $799 (-23% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $1,036 (25 August 2026) and about 18x forward earnings, the market prices Goldman close to a mid-cycle return on tangible equity, with the advisory and markets franchise neither breaking down nor re-rating. That is a demanding print for a firm whose revenue base swings with the deal and trading cycle. The twelve-month base-case target of $1,015 and the probability-weighted value of $1,005 sit close to the quote, but the blended anchor is $799, -23% against spot, leaving the shares trading rich to intrinsic value at a HOLD rating. The split in the tree is deliberate: the structural and recession paths together carry well over a third of the probability and drag the mean down through margin and multiple compression at once, while the growth and re-rate paths, carrying rather less, rely on a rate tailwind and buybacks the engine will only credit through the multiple, not through stretched earnings. Variance is dominated by the multiple rather than by earnings, so this is a question about the regime investors will capitalise. The single most damaging risk is a credit turn: charge-offs and provisioning rising while net interest margin compresses would collapse returns and de-rate the multiple simultaneously, which is precisely the structural path whose target sits below the 52-week low.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($1,036) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear mechanism is the structural credit and regulation path. Goldman's returns lean on an advisory and markets franchise that is procyclical by construction, and a credit turn does not arrive gently: provisioning spikes, net interest margin compresses as funding costs reprice faster than assets, and return on tangible equity falls through the low teens. The market does not de-rate earnings in isolation — it compresses today's 18x multiple at the same time, so the two move together and the target falls toward and through tangible-book support. Tighter capital rules would compound the damage by forcing a buyback suspension, removing the share-count reduction that flatters per-share earnings precisely when earnings are weakest. At roughly a fifth of the probability with a target beneath the 52-week low, this is not a tail hedge; it is the mechanism a skeptical holder should weigh most heavily.
Key Debate
P/E Multiple explains 74% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 14.6× consensus forward EPS, and a peer median 28.0×.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 72.1 | 64.6 | High |
| EPS | 70.8 | 56.4 | Medium |
| Target price | 1,141.7 | 1,015.0 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Credit Cycle / NIM Compression / Regulation' downside ($449) to a 'Bull — Re-Rate / Buybacks' bull case ($1,712); the probability-weighted blend (PWEV $1,005) is -3% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Credit Cycle / NIM Compression / Regulation | 20% | $449 | -57% |
| Recession — Heavy Provisioning | 17% | $756 | -27% |
| Base — Mid-Cycle ROTCE | 35% | $1,053 | +2% |
| Growth — Rate Tailwind / Loan & Fee Growth | 20% | $1,404 | +35% |
| Bull — Re-Rate / Buybacks | 8% | $1,712 | +65% |
| Probability-Weighted (PWEV) | — | $1,005 | -3% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 5.6% of revenue; free cash flow net of SBC is $-50.66B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Credit Cycle / NIM Compression / Regulation (20%, $449). Structural impairment — credit cycle / NIM compression / regulation: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Recession — Heavy Provisioning (17%, $756). Cyclical downturn — earning-asset growth + net interest spread + credit costs + fee income weakens for 1–2 years before normalising.
- Base — Mid-Cycle ROTCE (35%, $1,053). Mid-cycle — normalised earning-asset growth + net interest spread + credit costs + fee income; disciplined capital allocation; steady returns.
- Growth — Rate Tailwind / Loan & Fee Growth (20%, $1,404). Upside — rate tailwind + loan & fee growth lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Re-Rate / Buybacks (8%, $1,712). Upside tail — sustained tight conditions or a structural re-rate on rate tailwind + loan & fee growth.
Valuation Triangulation
Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $912 | -12% | 20% (declared 15%) |
| Peer P/E re-rate | multiple | $1,577 | +52% | 0% — excluded |
| Peer EV/Revenue re-rate | multiple | $-984 | -195% | 0% — cross-check only |
| Scenario PWEV | multiple | $1,005 | -3% | 33% (declared 25%) |
| Justified P/B (ROE-based) | book value × ROE | $603 | -42% | 47% (declared 35%) |
| Triangulated (weighted) | — | $799 | -23% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $912 + scenario PWEV $1,005, ≈ spot); the weighted blend $799 (-23%) sits below it because the cash-flow DCF ($603) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Book Value, ROE & Capital Returns
For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).
| Metric | Value |
|---|---|
| Book value / share | $356 |
| Return on equity (ROE) | 14.5% |
| Cost of equity (assumed) | 10.0% |
| Current P/B | 2.91x |
| Justified P/B (ROE-based) | 1.69x |
| Justified value / share | $603 (-42%) |
ROE of 14.5% comfortably clears the ~10% cost of equity — which is why a premium justified P/B of 1.69x (vs 2.91x current) is warranted. The justified value sits -42% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $912 and 37% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (74% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 28.0x) implies $1,577. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 281% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| MS | 18.8× | 5% | 41% | direct | 100% |
| SCHW | 14.5× | 7% | 49% | direct | 100% |
| IBKR | 37.2× | 7% | 77% | broad | 25% |
| HOOD | 47.6× | 7% | 38% | broad | 25% |
Quality-weighted forward P/E: 21.8× (simple median 28.0×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $678–$1,152, centre $884 (-15% vs spot); spot sits at the 76th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $799 (-23% vs spot · triangulated FV) |
| Downside to bear case (Structural — Credit Cycle / NIM Compression / Regulation) | $449 (-57% vs spot · bear scenario) |
| Reward-to-risk ratio | withheld — the triangulated FV is at or below spot, so there is no reward leg to divide by the risk leg |
| Margin of safety (FV vs spot) | -30% |
| P(price > spot) — Monte Carlo | 37% |
That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate / Buybacks): $1,712.
Company Overview & Business Model
Goldman Sachs Group Inc — FINANCIAL SERVICES · CAPITAL MARKETS. The Goldman Sachs Group, Inc., is an American multinational investment bank and financial services company headquartered in New York City. It offers services in investment management, securities, asset management, prime brokerage, and securities underwriting.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Banking (NII + Fees) | 100% | +5% | 33% | earning-asset growth + net interest spread + credit costs + fee income |
Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Banking (NII + Fees) | $61.5B | 100% | 5% | 33% | $20.5B | 18.0x | 1% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | earning-asset growth + net interest spread + credit costs + fee income |
| net_debt_or_cash_b | -742.46 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.01 |
| div_yield | 0.0146 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | credit cycle / NIM compression / regulation |
| upside | rate tailwind + loan & fee growth |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $-15.0B — net cash |
| Interest coverage (EBIT / interest) | 0.3x |
| Current ratio | 0.83x |
| Lease obligations | $2.2B |
| Cash & ST investments | $624.5B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $-47.2B |
| Buybacks / dividends | $12.4B / $5.3B |
| Total shareholder yield | 5.7% |
| Payout as % of FCF | -37.4% |
| Reinvestment (capex / OCF) | -4.6% |
| SBC as % of FCF | -7.3% |
| Allocation stance | reinvesting |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | -76.8% |
| FCF conversion (FCF / net income) | -274.9% |
| FCF yield | -15.4% |
| Capex intensity (capex / revenue) | 3.4% |
| FCF − SBC (diagnostic) | $-50.7B |
| Capex split (maint / growth) | 65% / 35% — Capital deployment is balance-sheet/RWA and technology-platform spend rather than physical capex; growth allocation is technology, trading infrastructure and selective AWM build. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) -263% — earnings not cash-backed.
Competitive Moat
Moat sources:
- Top-tier advisory/M&A and equity-underwriting league-table position and repeat institutional mandates
- Global markets (FICC/equities) trading franchise and risk-intermediation scale
- Elite talent pipeline and brand in capital markets
- No structural deposit-funding cost advantage vs universal banks — funding is wholesale-tilted and cyclical
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.40 vs analyst floor +0.00 → delta +0.40 (n=15 mgmt / 11 Q&A; 49th pctile across the S&P book, z -0.1).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.40 | +0.00 | +0.40 |
| 2026Q1 | +0.38 | +0.25 | +0.14 |
| 2025Q4 | +0.62 | +0.30 | +0.32 |
| 2025Q3 | +0.45 | +0.14 | +0.32 |
News (last 365d, 2588 articles): avg ticker sentiment +0.15 (bullish 6% / bearish 1%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $1,142 (+10% vs spot · street) |
| House target | $1,015 (-11.1% vs street) |
| Sell-side coverage | 25 analysts (SB 1 / B 6 / H 16 / S 1 / SS 1; net score 0.1) |
| Consensus FY EPS | $70.77; house below (-20.3%) |
| Consensus FY revenue | $72.1B; house below (-10.4%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-09-30 (~37d) — Basel III endgame final-rule capital-requirement clarity (authored)
- 2026-10-13 (~50d) — Quarterly earnings — est. EPS $15.62 (AV EARNINGS_CALENDAR)
- 2027-01-15 (~144d) — Full-year investor update on Asset & Wealth Management fee mix and platform-solutions run-off (authored)
Forecast Track Record
- EPS surprise: beat 100% of the last 8 quarters; average surprise +20.8%.
- Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 58%; mean predicted -3.5% vs realised -1.4%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
7 catalysts in the next 90 days (of 16 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-01 (in 7d) | Ex-dividend $5.00/sh | dividend | ● | 0.9 |
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-09-30 (in 36d) | Basel III endgame final-rule capital-requirement clarity | authored | ● | 0.7 |
| 2026-10-13 (in 49d) | Quarterly earnings | earnings | ●●● | 0.95 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-15 (in 143d) | Full-year investor update on Asset & Wealth Management fee mix and platform-solutions run-off | authored | ● | 0.7 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Basel III endgame raising RWA/capital requirements and lowering achievable ROTCE | high (~55%) | high - a structural ROTCE cap hits justified P/TBV, ~15-20% of FV | 12-24m |
| Stress Capital Buffer increase constraining buyback capacity | medium (~40%) | medium - lower return-of-capital slows per-share compounding, ~8-10% of FV | 12-24m |
| Consumer/credit-card (platform solutions) regulatory and provisioning scrutiny | medium (~35%) | low - a shrinking, non-core book, ~3-5% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Recession — Heavy Provisioning | Recession drives large credit provisions and depressed advisory/underwriting volumes. | Provision spike plus dealmaking drought crushes a single-year ROTCE and book growth. |
| Base — Mid-Cycle ROTCE | Mid-cycle capital-markets activity and normalised provisions deliver a low-to-mid-teens ROTCE. | Markets revenue is inherently volatile; a slow-issuance year undershoots the mid-cycle print. |
| Growth — Rate Tailwind / Loan & Fee Growth | Supportive rate curve, healthy issuance and AWM fee growth lift ROTCE above mid-cycle. | Rate/issuance tailwind reverses quickly; markets revenue does not compound like fees. |
| Bull — Re-Rate / Buybacks | Strong capital return and a durable-fee narrative re-rate P/TBV above 1.5x. | Re-rate depends on benign capital rules and a strong tape — both can reverse. |
Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.
Decision Rules (Machine-Checked)
Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 5 evaluable (1 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
-2.05 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
-2.05 | no |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.1 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
-262.9 | — |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.11 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.84 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Net interest margin < mid-cycle assumption by 20bps or more (2 consecutive prints). NIM compression below the base path signals the rate tailwind is reversing faster than the mid-cycle case assumes, pushing the mix toward the recession and structural scenarios.
- Net charge-off ratio > 0.75% annualised (2 consecutive prints). A charge-off ratio running above the through-cycle norm confirms the heavy-provisioning path and undermines the mid-cycle ROTCE that the base multiple relies on.
- ROTCE (annualised) < 11% (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- CET1 capital ratio < the standardised regulatory requirement plus buffer (single event). A CET1 ratio breaching the requirement-plus-buffer forces buyback suspension, which removes the share-count reduction the bull and growth paths depend on and signals regulatory tightening.
- Investment banking + markets revenue (trailing four quarters) < the base-path revenue assumption of $61.5B (2 consecutive prints). Goldman's fee and markets franchise carries most of the cyclicality; trailing revenue falling below the base assumption for two prints signals the deal and trading cycle is turning down toward the recession scenario.
Fact / Inference / Speculation
- FACT: Spot $1,036; 52-week range $678–$1,152; engine rating HOLD; house target $1,015 (-2%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $799 (-23% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
54.4/100 (confidence band 37.2–71.6), 35th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 28 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | — | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 48 | 15% | upside_pct |
| growth | 53 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 100 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 58 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 53 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 58 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (financial strength, macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 54.5 → 54.5 → 54.2 → 54.8 → 54.8 → 55.5 → 54.8 → 54.8.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Credit Cycle / NIM Compression / Regulation | 20% | $449 | -56.6% | -11.3pp |
| Recession — Heavy Provisioning | 17% | $756 | -27.1% | -4.6pp |
| Base — Mid-Cycle ROTCE | 35% | $1,053 | +1.7% | +0.6pp |
| Growth — Rate Tailwind / Loan & Fee Growth | 20% | $1,404 | +35.5% | +7.1pp |
| Bull — Re-Rate / Buybacks | 8% | $1,712 | +65.2% | +5.2pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | -3.0% |
| Expected return net of SBC dilution | -3.0% |
| Outcome dispersion (σ, from MC p10–p90) | 33.3% |
| Expected Sharpe (rf 4%) | -0.21 |
| Downside expectation (prob-weighted loss branches) | -15.9% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | -3.0% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 1.38 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 10.2% |
| Expected alpha | -13.2% |
| Alpha per unit risk (EA/σ) | -0.40 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 36.7% (1σ) | 24.3% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 63.0% | 36.7% | the scenario weights and the MC parameters disagree about our OWN view — this is a model-coherence issue, not a market disagreement |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $1004.72.
Flagged for review: internal coherence (authored mass vs Monte Carlo). A flag marks a disagreement worth understanding — it does not imply either side is wrong.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 49 | AI | 86 | |
| Value | 15 | Cloud | 79 | |
| Quality | 2 | Semis | 88 | |
| Momentum | 88 | Consumer | 72 | |
| Low-Vol | 17 | Rates | 64 | |
| USD | 24 | |||
| Energy | 17 |
Market interaction: correlation vs SPY +0.70, vs QQQ +0.61 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Long Stock. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- no directional edge and options are cheap — options add little; hold the stock
- Direction neutral from the overlay conviction/rating (read-only input).
- IV/RV at the 20th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 79th percentile of its own month-end history (decile 8). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +2.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
- No live-chain Long Stock was priced for this name — shown as the indicated strategy; size against a freshly pulled chain.
IV term structure (contango, slope +2.9pp): 32-DTE 33% · 88-DTE 34% · 297-DTE 36%
No live-chain Long Stock was priced for this name — shown as the indicated approach; size against a fresh chain.
Alternatives: . IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.32% NAV |
| Annualized outcome σ (MC) | 33.3% |
| Indicative holding period | 3–12 months |
| Liquidity | high, ~$2,055M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 32.7% (moderate regime) · expected move ±7.2% (2026-09-25) · put/call OI 0.81 · ATM Δ 0.54 / Θ -0.60 / ν 1.22 · next earnings 2026-10-13. Direction: NEUTRAL (implied return -6.4% to triangulated fair value $970.04).
Covered Call (if held) (Income / neutral) — Short 1110 C · 2026-09-25 · premium $12.32 · yield 1.2% · priced from the listed chain (EOD marks)
Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.
Put Spread (income) (Income / would-own) — Short 955 P / Long 880 P · 2026-10-02 · net $8.95 · net entry $946.05 · yield 0.9% · RoR 14.0% · max loss $66.05 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Protective Collar (if held) (Hedge) — Long 935 P / Short 1140 C · 2027-03-19 · net $12.17 · floor -10.0% · cap +10.0% · priced from the listed chain (EOD marks)
For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -3% vs spot
- Monte Carlo median implies -12% vs spot
- DCF fair value implies -42% vs spot
- Bear case (Structural — Credit Cycle / NIM Compression / Regulation) downside is -57% vs spot
- Net: the valuation anchor itself sits 22.9% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $61.5B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $64.6B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $70.767 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.296B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $-14.993B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.